There are so many things to consider as you plan your company’s return to work strategy. ARCpoint Labs can help you develop a plan that is specific to your workplace, that adheres to important safety measures set forth by federal, state and local government agencies and aims to reduce the risk of exposure for your employees.
The CDC now estimates that roughly 40% of COVID-19 transmissions are happening before people feel sick or show any symptoms, and 35% of those who have the virus never show symptoms at all. That means temperature checks alone are not enough to prevent the spread and protect your employees, and it emphasizes the importance of having a comprehensive testing strategy.
Whether it’s on-boarding new employees, determining what to do with contractors, or finding ways to bring previously sick employees back to work, we have the guidance you need to ensure compliance with government regulations while decreasing your risk.
For your employees that have experienced symptoms or been in close contact with others who were infected with the virus, by identifying the presence of the live virus in a donor, the viral test determines whether any of your employees currently have the virus and could possibly infect others. The viral test helps you make staffing decisions to avoid the spread of the virus in your workplace after an employee tests positive or when determining who should return to work and when by allowing you to identify infected employees.
Whether it’s on-boarding new employees, determining what to do with contractors, or finding ways to bring previously sick employees back to work, we have the guidance you need to ensure compliance with government regulations while decreasing your risk.
Fill out the form below to speak with a COVID-19 ANTIBODY BLOOD TEST EXPERT
* Important Information
The Antibody Test is a serology test which measures the amount of antibodies or proteins present in the blood when the body is responding to a specific infection. This test hasn’t been reviewed by the FDA. Negative results don’t rule out SARS-CoV-2 infection, particularly in those who have been in contact with the virus. Follow-up testing with a molecular diagnostic lab should be considered to rule out infection in these individuals. Results from antibody testing shouldn’t be used as the sole basis to diagnose or exclude SARS-CoV-2 infection. Positive results may be due to past or present infection with non-SARS-CoV-2 coronavirus strains, such as coronavirus HKU1, NL63, OC43, or 229E.
While the presence of antibodies doesn't necessarily prevent future infections, they can reduce the severity of future infections of the current COVID-19 strain
Loading Locator Software...
